Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

USA ...
Amazon Smile https://smile.amazon.com/ (bookmark)
choose MEBO RESEARCH INC
0.5% to MEBO on your purchases
(no extra cost to you)

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Thursday, November 29, 2018

Publication uBiome Grant Awarded to MEBO

uBiome Awards Grant to MEBO Research, a Public Charity, to Study the Dynamic of Gut Microbiota in Idiopathic Malodor Production

Click on icon to see article

A press release was published today about the nearly $500,000 worth of microbiome research grant awarded to MEBO by uBiome for the "Microbial Basis of Systemic Malodor and PATM Conditions (PATM)", ClinicalTrials.gov Identifier: NCT03582826.

The aim of this study is to support the gathering of comprehensive data to assess the correlation of gut microbiome to physical and psycho-social health conditions.

“This study is exciting because it advances our understanding of metabolic dysfunction and its correlation to rare disease,” said Jessica Richman, PhD, co-founder and CEO of uBiome. “We are honored to partner with MEBO Research to support this novel study on this understudied patient population.”

Dr. Irene Gabashvili, PhD, is Scientific Director of MEBO Research and Principal Investigator. A Stanford Medicine and HP Labs alumna, Dr. Gabashvili has authored numerous publications and has led several diverse biomedical and software development projects. In addition, as founder of Aurametrix, Inc., she developed a health-management platform to alleviate metabolic disorders and maximize health and wellbeing.
"We are very excited to partner with uBiome for this joint project. Part of MEBO’s mission as a charity is to pursue studies on gut microbiota to understand gut health and the microbial communities that produce malodor symptoms. uBiome is an innovator in microbiome analysis.” - Maria de la Torre"

This very generous grant allows for MEBO to include participants, who experience similar physical symptoms with psycho-social health conditions, from 6 continents of the world, including Africa, Europe, Asia, North America, South America, and Australia. Our profound gratitude goes out to the uBiome team for their very kind and professional support throughout this process.

Latest posts about the study :
Link
(Scroll down to see all posts)


María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.com
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

0 comments:

Post a Comment